These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8293855)
1. [Unidentified steroid hormone of Cushing's syndrome and disease]. Suzuki T; Sakuta H; Nakagawa K; Iwata J; Ito T Nihon Naibunpi Gakkai Zasshi; 1993 Dec; 69(11):1139-52. PubMed ID: 8293855 [TBL] [Abstract][Full Text] [Related]
2. Micro-analytical identification, by NMR, of elevated steroid in urine of Cushing's syndrome patients. Iwata J; Kinumaki A; Morita H; Yasuda K Endocr J; 2003 Jun; 50(3):255-61. PubMed ID: 12940453 [TBL] [Abstract][Full Text] [Related]
3. Daily excretion levels of an unidentified ketosteroid in the urine of patients with Cushing's syndrome and healthy subjects measured by a new method. Iwata J; Morita H; Yasuda K; Kuwayama A; Suzuki T; Demura H Endocr J; 1995 Jun; 42(3):449-53. PubMed ID: 7670574 [TBL] [Abstract][Full Text] [Related]
4. [Evaluation of various parameters in the differential diagnosis of Cushing's disease and Cushing's syndrome caused by adrenal adenoma]. Lu ZL; Zhang GX; Liu W Zhonghua Nei Ke Za Zhi; 1989 Jan; 28(1):28-31, 62. PubMed ID: 2737034 [TBL] [Abstract][Full Text] [Related]
5. Cortisol and its metabolites in the plasma and urine in Cushing's syndrome with chronic renal failure (CRF), compared to Cushing's syndrome without CRF. Otokida K; Fujiwara T; Oriso S; Kato M Nihon Jinzo Gakkai Shi; 1989 Jun; 31(6):651-6. PubMed ID: 2795994 [TBL] [Abstract][Full Text] [Related]
6. Effect of o,p'-DDD on cortisol metabolism in Cushing's syndrome of various etiology. Koide Y; Inoue S; Murayama H; Kawai K; Yamashita K Endocrinol Jpn; 1985 Oct; 32(5):615-24. PubMed ID: 3004927 [TBL] [Abstract][Full Text] [Related]
7. [A case of Cushing's syndrome due to bilateral multiple adrenal adenomas]. Ashida S; Kataoka S; Yamasaki I; Yamashita M; Ohashi Y; Morioka M; Shuin T Hinyokika Kiyo; 1997 Aug; 43(8):567-70. PubMed ID: 9310779 [TBL] [Abstract][Full Text] [Related]
8. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma. Jimenez-Alonso J; Munoz-Avila J; Jaimez L; Pérez-Jimenez F; Bellido C; Jiménez-Perepérez JA Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736 [TBL] [Abstract][Full Text] [Related]
9. Urinary free cortisol and cortisone determined by high performance liquid chromatography in the diagnosis of Cushing's syndrome. Lin CL; Wu TJ; Machacek DA; Jiang NS; Kao PC J Clin Endocrinol Metab; 1997 Jan; 82(1):151-5. PubMed ID: 8989250 [TBL] [Abstract][Full Text] [Related]
10. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398 [TBL] [Abstract][Full Text] [Related]
12. Circulating adrenomedullin is increased in patients with corticotropin-dependent Cushing's syndrome due to pituitary adenoma. Letizia C; Di Iorio R; De Toma G; Marinoni E; Cerci S; Celi M; Subioli S; D'Erasmo E Metabolism; 2000 Jun; 49(6):760-3. PubMed ID: 10877203 [TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome due to adrenal adenoma with persistent diurnal cortisol secretory rhythm. Olsen NJ; Fang VS; DeGroot LJ Metabolism; 1978 Jun; 27(6):695-700. PubMed ID: 206799 [TBL] [Abstract][Full Text] [Related]
14. Cushing's syndrome with a paradoxical response to dexamethasone. French FS; Macfie JA; Baggett B; Williams TF; Van Wyk JJ Am J Med; 1969 Oct; 47(4):619-24. PubMed ID: 4309844 [No Abstract] [Full Text] [Related]
15. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor. Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526 [TBL] [Abstract][Full Text] [Related]
16. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome. al-Saadi N; Diederich S; Oelkers W Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067 [TBL] [Abstract][Full Text] [Related]
18. [Cushing's syndrome and adrenal adenoma. Two surprising associations]. Ouzounian S; Tissier F; Gouya H; Kujas M; Louvel A; Legmann P; Bertagna X Presse Med; 2005 Apr; 34(7):511-5. PubMed ID: 15903005 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells? Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339 [TBL] [Abstract][Full Text] [Related]
20. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy. Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]